期刊文献+

6种常见耐药标志物在氟尿苷耐药绒癌细胞系构建过程中的动态表达 被引量:3

Dynamical mRNA Expression Profiles of Six Common Chemo-resistance Related Genes in Floxuridine-resistance Human Choriocarcinoma JEG-3 Cell Line
下载PDF
导出
摘要 目的:通过检测对氟尿苷(FUDR)耐药的绒癌细胞系构建过程中肺耐药相关蛋白(LRP)、二氢叶酸还原酶(DHFR)、survivin、谷胱甘肽S-转移酶-π(GST-π)、多药耐药基因(MDR1)和多药耐药相关蛋白基因(MRP)6种常见耐药标志物的动态表达,探讨其耐药机制并进行耐药标志物的初步筛选。方法:用化学发光法和荧光定量PCR技术,分别检测不同浓度FUDR诱导的JEG-3细胞中β-人绒毛膜促性腺激素(β-HCG)的分泌量和上述6种常见耐药标志物在耐药细胞构建过程中的动态表达。结果:不同基因在药物诱导过程中的变化趋势不尽相同。只有LRP基因的表达随着诱导药物浓度和肿瘤细胞耐药性的增加而逐渐上调。结论:耐药的产生是分阶段的,不同阶段有不同的因素参与。就目前的研究结果而言,只有LRP的表达变化与FUDR诱导浓度和耐药性有明显正相关,提示其可以作为绒癌对FUDR耐药的候选预测指标。 Objective:To assess whether the transcript level of lung resistance-related protein (LRP), dihydrofolate reductase( DHFR), glutathione-S-transferase-π (GST-π), multidrug resistance gene ( MDR1 ) multidrug resistance protein (MRP) and survivin can be used for screening the floxuridine(FUDR) -based chemoresistant biomarker. Methods:Quantitative RTPCR was used to measure these six genes mRNA expression in JeG -3 cell lines during different concentrations of FUDR-exposureo 13 subunit human chorionic gonadotropin (β-HCG) in the culture medium was detected by chemo-luminescence. Results:The changing tendency of the different genes were different,only LRP gene showed gradual upregulation when the concentration or chemoresistance of Floxuridine increased. Conclusions: The genesis of chemoresistance is step by step, and variable factors are involved in different stages. From this pilot study,only the expression change of LRP is coincident with the concentration and chemoresistance of Floxuridine,so it can be a candidate prognostic marker for detecting chemoresistance in choriocarcinoma patients.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2011年第1期24-27,共4页 Journal of Practical Obstetrics and Gynecology
基金 国家自然基金资助(项目编号:30973178)
关键词 绒癌 JEG-3细胞系 耐药 氟尿苷 Choriocarcinoma JEG-3 cell line Chemo-resistant Floxuridine
  • 相关文献

参考文献9

  • 1Kim S,Park DH.Shim J.Thymidylate synthase and dihydrepyrimidine dehydrogenase levels are associated with response to 5-fluorouracil in Cannorhabditis elegans[J].Mol Cells,2008,26(4):344-349.
  • 2韩冰,向阳,沙桂华,张浩,刘欣.绒毛膜癌氟尿苷耐药细胞系的建立及其胸苷合成酶的表达[J].中华妇产科杂志,2009,44(11):851-855. 被引量:6
  • 3Stein U,Bergmann S,Seheffer GL.et al.YB-1 facilitates basal and 5-fluorouraclL-inducible expression of the human major vault protein(MVP)gene[J].Oncogene,2005,24(22):3606-3618.
  • 4Hagmann W,Jesnowski R,Faissner R.et al.ATP.binding cassette C transportem in human pancreatic carcinoma cell lines.Upregulation in 5-fluomuraclL-resistant ceHs[J].Pancreatology,2009,9(1-2):136-144.
  • 5Derveanx S,Vandesompele J,Hellemans J.How to do successful gene expression analysis using real-time PCR[J].Methods,2010,50(4):227-230.
  • 6Di Nicolantonio F,Mercer SJ,Knight LA.et al.Cancer cell adaptation to chemotherapy[J].BMC Cancer,2005,5(2):78.
  • 7Perez-Tomas R.Multidrug resistance:retrospect and prospects in anti-cancer drug treatment[J].Curr Med Chem,2006,13(16):1859-1876.
  • 8Sekine 1,Minna JD,Nishio K,et al.Genes regulating the sensitivity of solid tumor cell lines to eytotoxic agents:a literature review[J].Jpn J Clin Oacol,2007,37(5):329-336.
  • 9Lage H.Therapeutic potential of RNA interference in drug-resistant cancels.[J].Future Oncol,2009,5(2):169-185.

二级参考文献15

  • 1Li L, Luan Y, Wang G, et al. Development and characterization of five cell models for chemoresistance studies of human ovarian carcinoma. Int J Mol Med, 2004, 14:257-264.
  • 2Matsui H, Iitsuka Y, Suzuka K, et al. Salvage chemotherapy for high-risk gestational trophoblastic tumor. J Reprod Med, 2004, 49:438-442.
  • 3Cunningham FG, Gant NF, Kenneth JL. Williams Obstetrics. 21 st. New York : McGraw-hill ,2002:569.
  • 4Jakoby WB. Methods in enzmology, Vol I. Cell culture. New York: Acad Press, 1979 : 150.
  • 5Lala PK, Lee BP, Xu G, et al. Human placental trophoblast as an in vitro model for tumor progression. Can J Physiol Pharmacol, 2002, 80 : 142-149.
  • 6van Laar JA, Rustum YM, Ackland SP, et al. Comparison of 5- fluoro-2'-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer. Eur J Cancer, 1998, 34:296-306.
  • 7Maring JG, Groen HJ, Wachters FM, et al. Genetic factors influencing pyrimidine-antagonist chemotherapy. Pharmacogenomics J, 2005, 5 :226-243.
  • 8Snow K, Judd W. Characterisation of adriamycin- and amsacrine- resistant human leukaemic T cell lines. Br J Cancer, 1991, 63: 17-28.
  • 9van Triest B, Pinedo HM, van Hensbergen Y, et al. Thymidylate synthase level as the main predictive parameter for sensitivity to 5- fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. Clin Cancer Res, 1999, 5:643-654.
  • 10Aschele C, Debernardis D, Bandelloni R, et al. Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5- lluorouracil but not methotrexate-modulated bolus 5-fluorouracil. Ann Oncol, 2002, 13 : 1882-1892.

共引文献5

同被引文献33

  • 1向阳.宋鸿钊滋养细胞肿瘤学.3版.北京:人民卫生出版社,2011: 78- 262.
  • 2Scionti I, Michelacci F, Pasello M, et al. Clinical impact of the methotrexate resistance associated genes C - MYC and di- hydrofolate reductase (DHFR) in high grade osteosarcoma. Ann Oncol, 2008, 19: 1500-1508.
  • 3Gori JL, Tian X, Swanson D, et al. In vivo selection of hu- man embryonic stem cell - derived cells expressing methotrex- ate resistant dihydrofolate reductase. Gene Ther, 2010, 17: 238 - 249.
  • 4Rotsmg MG, Willey GC, Janseng G, et al. mRNA expres- sion levels of methotrexate resistance - related proteins in childhood leukem is as determined by a standerrized competi- tive template- based RT- PCR method. Leukemia, 2000, 14: 2166- 2175.
  • 5Scheper RJ,Broxterman HJ,Scheffer GL. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance[J].{H}CANCER RESEARCH,1993,(07):1475-1479.
  • 6Hyogotani A,Ito K,Yoshida K. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer[J].Clin Lung Cancer,2012,(05):375-384.
  • 7Wang J,Zhang J,Zhang L. Expression of P-gp,MRP,LRP,GST-π and TopoⅡα and intrinsic resistance in human lung cancer cell lines[J].{H}Oncology Reports,2011,(05):1081-1089.
  • 8Thiyagarajan S,Thirumalai K,Nirmala S. Effect of curcumin on lung resistance-related protein (LRP) in retinoblastoma cells[J].{H}CURRENT EYE RESEARCH,2009,(10):845-851.
  • 9Kerr EH,Frederick PJ,Egger ME. Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma[J].{H}ANNALS OF SURGICAL ONCOLOGY,2013,(09):3059-3065.
  • 10Tsuji K,Wang YH,Takanashi M. Overexpression of lung resistance-related protein and P-glycoprotein and response to induction chemotherapy in acute myelogenous leukemia[J].Hematol Rep,2012,(03):18.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部